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Abstract
Background:  Low back pain (LBP) is a major public health problem. Risk factors for the
development and persistence of LBP include physical and psychological factors. However, most
research activity has focused on physical solutions including manipulation, exercise training and
activity promotion.
Methods/Design: This randomised controlled trial will establish the clinical and cost-effectiveness
of a group programme, based on cognitive behavioural principles, for the management of sub-acute
and chronic LBP in primary care. Our primary outcomes are disease specific measures of pain and
function. Secondary outcomes include back beliefs, generic health related quality of life and
resource use. All outcomes are measured over 12 months. Participants randomised to the
intervention arm are invited to attend up to six weekly sessions each of 90 minutes; each group
has 6–8 participants. A parallel qualitative study will aid the evaluation of the intervention.
Discussion: In this paper we describe the rationale and design of a randomised evaluation of a
group based cognitive behavioural intervention for low back pain.
Background
Low back pain (LBP) is a major public health problem
[1,2]. In the UK, the annual period prevalence of LBP is
approximately 37% [3,4]. A study conducted in the UK
found that 75% of people with LBP who consulted their
general practitioner (GP) still had symptoms one year
later; 30% had developed persistent disabling LBP [5,6].
The direct health care costs associated with LBP in 1998
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were £1628 million; the majority of this was spent on
physiotherapy and general practice [1].
Since the early 1990s there has been a change in the
emphasis of LBP treatment with strong discouragement of
bed rest and encouragement of physical activity becoming
an orthodox approach. This active management strategy
forms the core of all international guidelines for the man-
agement of acute (< 3 months) LBP [7-12]. Less attention
has been paid to the management of chronic low back
pain. The active management approach is sometimes sup-
plemented with patient education materials. In the UK,
'The Back Book' is advocated [13,14]. Evidence to support
other physical treatments is weak [15]. A recent UK study
found no difference between six sessions of physical ther-
apy and a single session of active management supple-
mented by 'The Back Book' [16] There are no
recommendations relating to the use of psychologically
based treatments [17].
A number of studies indicate that cognitive behavioural
approaches (CBA) may be beneficial in the management
of sub-acute and chronic LBP [17-22]. However, none of
the trials to date has been of sufficient size or duration to
determine long-term clinical and there has been little
attention paid to the cost effectiveness of CBA.
Applications of CBA for LBP have varied in content and
method of delivery [23]. In the UK, the first applications
of CBA were in-patient pain management programmes for
very chronic low back pain. CBA appears moderately
effective in this context [18], but the effect on people pre-
senting in general practice, often with less severe symp-
toms, is unknown. Although not formally reported, pain
management programmes are expensive because of the
intensity of intervention and high staff costs. Less expen-
sive CBA, such as short group programmes led by a nurse
or therapist, would appear highly applicable to general
practice, but have not been widely implemented or stud-
ied in such settings. Potential advantages include; prevent-
ing chronic disability, increasing physical and
psychosocial functioning in patients with disability due to
low back pain, and decreasing inappropriate health care
utilisation. In other chronic conditions the social interac-
tions and comparisons that occur in a group-based inter-
vention have been identified as potentially important
mediators of the therapeutic effect [24]. The Back Skills
Training Trial (BeST) has been designed to capture and
evaluate these effects using a combination of qualitative
and quantitative methodologies.
There is a need to establish if group based CBA is an effec-
tive approach in the management of sub-acute and
chronic LBP, and if baseline characteristics are important
predictors of treatment response. We will determine the
effectiveness of adding a group based, professionally led
CBA for LBP to active management in general practice on
• LBP related pain and disability
￿ time lost from occupational activity
￿ fear avoidance beliefs
￿ the use of further medical, rehabilitation, surgical or
alternative treatments for LBP
￿ generic health related quality of life
￿ health service costs.
The target population are individuals with low back pain
of at least moderate troublesomeness and of at least six
weeks duration. The effects will be monitored over a 12-
month period. Evaluation will include an appropriate
method of cost appraisal which will consider both the
health and societal perspective.
Methods/Design
Setting
Around 98% of the UK population is registered with a
general practitioner. We are recruiting participants from
97 general practices, with a total list size of 700,000
patients in seven localities (Primary Care Trusts) across
England; South Warwickshire, North Warwickshire, Cov-
entry, Solihull, North Norfolk, Southern Norfolk, Nor-
wich, Broadland, Langbaugh, Heart of Birmingham, and
South Birmingham. The population in these localities is
broadly representative of the population of England. Par-
ticipants from practices in each locality are able to attend
the same treatment centre ensuring sufficient numbers to
sustain the group sessions without making participant
travel burdensome.
Ethical approval
West Midlands Multi-Centred Research Ethics Commit-
tee, Birmingham UK (MRC/03/7/04) provided the ethical
review and approval.
Study Population
Potential participants who have consulted their general
practice with back pain in the last six months are identi-
fied by searching the practice computerised medical
record or are identified by practice clinical staff when they
attend the practice. They are sent an invitation letter and
eligibility questionnaire by post. Those people who indi-
cate a willingness to participate, and fulfil the first stage
eligibility criteria are invited to an initial interview with a
research nurse at which there are further eligibility checks,
and potential participants are provided with a detailedBMC Musculoskeletal Disorders 2007, 8:14 http://www.biomedcentral.com/1471-2474/8/14
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explanation of the study purpose and procedures. At a sec-
ond appointment, at least one week later, informed con-
sent is obtained, baseline data are collected, the
participant is randomised and the 'active management
approach' to managing back pain is reinforced. This
includes providing all participants with a copy of 'The
Back Book'.
Eligibility criteria
Inclusion criteria are LBP of at least moderate trouble-
someness and of at least six weeks duration; age greater
than 18 years; willing and able to give informed consent
and to understand/speak English. People are ineligible if
they have been managed previously in a cognitive behav-
ioural programme; have "Red Flags" i.e. factors associated
with serious LBP pathology (including cauda equina
symptoms, systemic illness (including cancer, HIV, fever);
widespread neurological problems, severe unremitting
night-time pain, violent trauma (fall from height, RTA),
unexplained weight loss); or have severe psychiatric or
personality disorders. There is consensus that CBA and
related interventions are unnecessarily intensive for peo-
ple who suffer an isolated acute or minor episode of LBP,
in whom symptoms resolve quickly and pose no on-going
problem [25]. We are seeking to recruit participants with
at least moderately troublesome sub-acute or chronic low
back pain [26]. Measuring 'troublesomeness'/'bother-
someness' is a simple criterion for determining overall
symptom burden [27,28].
Baseline Assessment
Data are collected using a standard pro forma adminis-
tered by a specially trained research nurse. These include
age, gender, ethnicity, educational attainment, general
health status, duration of LBP, symptoms, recent treat-
ment history, anxiety and depression (using the Hospital
Anxiety and Depression Scale [29]) and employment sta-
tus. In addition participants complete the baseline (pre-
intervention) versions of the outcome measure package
(see Table 1).
Treatment allocation
Following completion of the baseline assessment, the
research nurse completes a randomisation form and tele-
phones a central randomisation office to obtain the treat-
ment allocation. A minimisation algorithm is used to
ensure that, within each treatment arm, near equal num-
bers of participants are entered from each centre within
the differing levels of troublesome back pain (moderately
or very/extremely troublesome). The nurse provides the
advice component of the intervention to all study partici-
pants, and for participants randomised to CBA, sends a
notification letter to the local service provider. The service
provider then contacts the participant to arrange a day/
time to start the CBA treatment. Fig 1
Experimental intervention
Back Skills Training is a 'complex' intervention, compris-
ing a number of components that may act both independ-
ently and inter-dependently [30]. The components are;
(i) education to counter unhelpful beliefs about LBP and
to highlight the importance of appropriate levels of activ-
ity;
(ii) use of cognitive re-structuring techniques to counter
unhelpful beliefs;
(iii) training on goal setting, baseline setting, and pacing
for incrementally increasing activities;
(iv) specific focus on fear avoidance and attentional
effects on pain;
(v) techniques for self-management of pain especially in
flare-ups.
Table 1: Outcomes measures
Domain Measures Time points (months)
Primary Pain & Disability Roland & Morris Questionnaire (Roland 1983) 0, 3, 6, 12
Pain Von Korff Scale (Von Korff 1992) 0, 3, 6, 12
Secondary Occupational and other limitations Numbers of days off work, reduced activity and bed 
rest
0, 3, 6, 12
Health related quality of life inc physical & 
mental health
Short Form 12 version 2 (Ware 1996) 0, 3, 6, 12
Back Pain Beliefs Fear avoidance scale (1st five items only)* (Waddell 
1993)
0, 3, 6, 12
Self-efficacy Pain self-efficacy questionnaire (Nicholas 2006) 0, 3, 6, 12
Satisfaction with treatment Single item rating of satisfaction with treatment 
(Deyo et al 1998)
12
Economic analysis Resource Use Resource use questionnaire 6, 12
Health related quality of life; time trade off 
score
EQ-5D (health utility) (EuroQol Group 1990) 0, 6, 12BMC Musculoskeletal Disorders 2007, 8:14 http://www.biomedcentral.com/1471-2474/8/14
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Flow diagram of the study Figure 1
Flow diagram of the study
For potential participant appointments arranged
APPOINTMENT 1
(Computerised first nurse assessment questionnaire)
- explain the trial
- determine eligibility
- make appointment for randomisation assessment
IDENTIFICATION OF PARTICIPANTS
GP identifies and notifies the nurse or GPRF nurses identify potential participants from
patient records who are:
-  aged 18 and older;
- reporting LBP of at least moderate troublesomeness for more than 6 weeks;
-  are able to give informed consent
- After consent from GP, nurse posts an invitation including initial approach questionnaire
    to participate in the study
R
CBA + Active management (n=467) Active management (n= 233)
For all potentially eligible participants only
APPOINTMENT 2
(Computerised nurse randomisation assessment form)
-  check eligibility
- gain informed consent (for study)
-  complete baseline questionnaire
RANDOMISE PARTICIPANT
- fill in randomisation form
- Contact the randomisation centre
-  inform the randomisation centre of :- 
x the participant’s number;
x the participant’s gp practice/back pain centre;
x the severity of back pain (moderate or very/extremely
troublesome).
Randomisation centre to inform nurse of the participants treatment
- nurse contact the CBA therapist in their local area; 
- therapist contact the participant and book them on a CBA
course;
- nurse to given participant advice regards back pain and
also supply Back Book;
-  to refrain from other treatments where possible
FOLLOW-UP
Postal questionnaires sent from GPRF to participants – at 3, 6 and 12 months
- nurse to give participant advice regards
back pain and supply Back Book;
-  to refrain from other treatments where
possibleBMC Musculoskeletal Disorders 2007, 8:14 http://www.biomedcentral.com/1471-2474/8/14
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These components are delivered using a cognitive behav-
ioural model and focus on group problem solving to
increase self-efficacy. The treatment sessions are delivered
to groups of approximately 6–8 patients, using six weekly
sessions of 90 minutes length each. The rationale and the
components will be described in detail elsewhere. A par-
ticipant is deemed to have received the intervention if they
attend the baseline assessment, and three of the six fol-
low-up sessions. Therapists and nurses receive a one and
half day training programme including basic principles of
the cognitive behavioural approach, questioning, facilita-
tion of groups, pacing, coping, relaxation, exercise, and
pain management. Training and support are provided by
a qualified cognitive behavioural therapist and physio-
therapist. The intervention is structured around standard-
ised sessions and supplemented by a participant
workbook.
Other treatments
All participants receive a simple active management inter-
vention including a copy of 'The Back Book' [13]. The
important components of the active management strategy
are emphasised by the research nurse; namely,
￿ Encouragement to remain active and resist bed rest.
￿ Advice on appropriate methods of pain control.
Before starting the study the research nurses are trained in
delivery of the active management strategy supplemented
by 'The Back Book' [13]. Participants are asked to act on
the guidance. Participants can if they wish seek further
assistance from their GP or chosen back care provider. GPs
are able to refer patients to any other services that they
consider appropriate.
Outcome measures
The hypothesised benefits of a CBA are;
a) improvements in pain and LBP disability,
b) improved tolerance to pain, increased self-efficacy and
decreased depression,
c) improvements in overall quality of life
d) an increase in activity, particularly in those activities
that are avoided due to fear of pain or symptoms,
e) a shift toward self-management of LBP symptoms and
disability,
f) a reduction in use of self-paid and/or NHS treatments.
The outcome measures (shown in Table 1) have been
selected to cover these domains, and to maximise general-
isability, and have utilised the outcome data set recom-
mended by the International Low Back Pain Forum where
appropriate [2]. The primary outcome is the Roland and
Morris Questionnaire which (RMDQ) [31] is one of the
most widely used measures for LBP in primary care. It has
acceptable reliability [32,2,33] but concerns are emerging
about its scalability and sensitivity to clinically important
change [34]. Therefore, have a second primary outcome
with the modified Von Korff Scale [35] and we will under-
take additional analyses to compare the psychometric
properties of the two measures. The secondary outcome
measures are:
(i) the number of days (defined as greater than 1/2 a day)
participants have had to cut down on normal activity in
the preceding four weeks;
(ii) number of days participants had time off work
because of low back pain or leg pain (sciatica);
(iii) psychological measures as captured on the fear avoid-
ance beliefs questionnaire, pain self-efficacy
(iv) health-related quality of life as assessed using the SF-
12 Version 2;
(v) satisfaction with treatment measured using a standard-
ised and recommended single-item question [2] – 'How
satisfied are you with the treatment you received?'. The
response is measured on a five point Likert scale ranging
from very dissatisfied to very satisfied.
If the intervention is successful participants should be
able to utilise cognitive skills to manage symptoms over a
prolonged period; so we will measure the potential bene-
fits over a 12-month follow up period. The timing of var-
ious assessments is shown in Table 1.
Sample size
The sample size has been estimated using well-docu-
mented methods [36], with careful consideration of the
practicalities to ensure that sufficient numbers of partici-
pants are randomised within an acceptable time frame.
We originally planned a 1:1 randomisation ratio between
CBA and usual care. Early in the trial we recognised that a
2:1 randomisation (in favour of CBA) had distinct advan-
tages in ensuring that sufficient numbers of patients are
randomised to sustain the group sessions. A randomisa-
tion balance of 2:1 can be adopted with inconsequential
loss of power, but further imbalances necessitate an
increase in study size. From a list size of 100,000 (approx-
imating to one location), with twice as many participants
being randomised to the intervention group, we estimatedBMC Musculoskeletal Disorders 2007, 8:14 http://www.biomedcentral.com/1471-2474/8/14
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the yield of participants randomised to the group sessions
was 1.4 per week, allowing us to recruit eight participants
to a new group starting every six weeks. This estimate was
based on data from the UK BEAM trial [37].
The potential impact of the group effect was also consid-
ered in the sample size estimation. In this trial, other
effects include the individual practitioner treating several
groups, regions and organisations. We perceive that the
most potent of the cluster effects is the group effect, and is
the only effect to have been considered formally in the
sample size estimation (using methods described by
[38]).
The sample size target for the trial is 700 to detect a mod-
erate effect size, and a difference between the groups of
approximately 1.8 RDQ points, assuming a standard devi-
ation of 4.27 points (giving an effect size of 0.42). Approx-
imately 233 participants will be randomised to active
management alone and 467 participants on the active
management + CBA arm of the trial. The sample size has
been inflated to account for an inter-cluster correlation
co-efficient of 0.01 (based on UK – BEAM [37] and incor-
porates a loss to follow up of 25%. We have used a power
of 90% and p < 0.01 [39]. Effect sizes of approximately 0.4
are considered to be clinically worthwhile for back pain
interventions [23]. The sample size requirement will be
reviewed by an independent data monitoring committee
at approximately the mid point of data accumulation.
Data analysis
Primary analyses will be by intention-to-treat, i.e. patients
will be analysed in the groups to which they were ran-
domised, regardless of the treatment that they may have
received. The main study outcomes will be summarised as
the Area under the Curve (AUC) over the 12 month follow
up period. The AUC will be calculated by summing areas
under the graph between each pair of consecutive obser-
vations for an individual. Thus the AUC is a weighted
average of the outcome scores at each individual time
point weighted by the time between the observations.
Mean/median (depending on the distribution of the data)
AUC between the two treatment groups will then be com-
pared by a two independent sample t-test/Wilcoxon rank
sum test and include reporting of the 95% confidence
intervals for the mean/median difference in the AUCs.
One of the advantages of the AUC method is that a sensi-
tivity analysis may be easily performed to investigate the
effect of missing data. In the case of large missing data,
imputation techniques will be considered. In addition
outcomes will be reported separately for the 3 month time
point to characterise the early response to treatment.
Multi-level modelling will be used to estimate group, ther-
apist and other effects as appropriate.
Sub-group analyses
The potential biases inherent in undertaking multiple
sub-group analyses are well recognised [40]. However, the
BeST trial offers a unique opportunity to generate hypoth-
eses about the profile of patients most likely to benefit
from group based CBA. The most scientifically robust
method of sub-group analysis is a test of interaction
between treatment and outcome that has been appropri-
ately powered. It is widely recognised that powering a sub
group analysis can dramatically increase sample size
requirement. A rough rule is that detection of interactions
approximately twice the size of the main effect requires no
increase in the sample size, provided that the sub-groups
are of equal size, the sub-group comparisons are limited
and pre-specified, and the results are considered hypothe-
ses generating as opposed to confirmatory [40]. We will
report two pre-specified analyses alongside the main trial
results, namely a comparison of treatment effect in those
groups
i) with sub-acute versus chronic low back pain at study
entry.
ii) with moderately versus very/extremely troublesome
back pain at study entry.
iii) With high versus low fear avoidance at study entry.
These comparisons assume that detection of large effects,
and that sub-groups are of roughly equal size.
Discussion
Estimates of cost consequences
LBP has a range of costs and consequences across health-
care and patients. Once data collection is complete, the
costs and consequences of each treatment arm will be
compared from a societal as well as from a health care per-
spective. The cost of each treatment strategy is being deter-
mined prospectively and includes staff time, overheads,
equipment and transport. We are administering a closed
structure questionnaire to participants during the follow
up period (see Table 1), to ascertain whether participants
have had additional NHS or private treatment for their
LBP and whether this was paid for by the individual or
insurance provider. Participants are asked about medica-
tion over the preceding 4 weeks, and to distinguish
between prescription and over-the-counter expenses.
Patient self-reported information on service use has been
shown to be accurate in terms of intensity of use of differ-
ent services [41].
NHS service use associated with each treatment arm is col-
lected across study sites. The resource use estimates will be
complemented by other national sources. In order to
value the cost of these services, it will be assumed thatBMC Musculoskeletal Disorders 2007, 8:14 http://www.biomedcentral.com/1471-2474/8/14
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average costs reasonably reflect the long run marginal
costs of provision of services. The use of primary care and
hospital services will be costed from a variety of sources,
including the finance departments of the hospitals, PCTs
concerned and national sources [42]. There will be uncer-
tainties in many of the statistical estimates (e.g. mean
number of GP visits) and certain assumptions (e.g. the
average cost per visit). A careful analysis of the sensitivity
of any observed cost differences between areas will be
undertaken, based on the confidence intervals around the
statistical estimates and alternative assumptions. Multi-
way analysis will be undertaken along with an estimate of
critical values of key variables that can reverse the result.
Full economic evaluation will be performed based on a
comparative assessment of the marginal costs and out-
comes of the two treatment regimes used. A cost-utility
analysis will present the incremental cost of the extra ben-
efit gained; costs for any improvement of the health status
index (EQ-5D) will be calculated over time. This will be
done both in summary form in terms of incremental cost
per QALY, and also using a 'disaggregated' approach
where the extra costs are presented alongside the outcome
gains in terms of improvements in pain, physical activity,
mental well-being etc. In all these analyses, the uncertain-
ties in the cost and outcomes data will be incorporated
into a sensitivity analysis. Resource implications will be
combined with estimates of effectiveness derived for the
two components of the trial [43].
Qualitative study
A parallel qualitative study is designed to increase our
understanding of the participant's experience of back pain
and treatment and to provide detailed descriptive data to
inform transferability of the trial outcomes to other indi-
viduals, context and similar interventions. A researcher
experienced in social science methodology is conducting
in-depth interviews with approximately 30 individuals
(15 from each treatment arm). Sampling is for diversity of
age, severity of disability at entry into the trial and fear
avoidance. The interviews are following a semi-structured
approach, and are audio-taped and transcribed. Data
analysis will use the framework approach [44]). Qualita-
tive data will be collected on two occasions: after ran-
domisation and 12 months after treatment.
We have presented the rationale and design of a trial to
evaluate a complex intervention to improve low back
pain. Trial recruitment has commenced and is due to close
in March 2007. Follow up will continue until June 2008,
and results will be finalised for publication by January
2009.
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